Peri-Implantitis Market By Treatment Type (Non-Surgical Treatments {Mechanical Debridement, Antiseptics, Antibiotic Therapy, Laser Therapy}, Surgical Treatments {Flap Surgery, Bone Grafting, Soft Tissue Augmentation, Implantoplasty}, Adjunctive Therapies), By Product (Implant Cleaning Devices {Ultrasonic Scalers, Air-polishing Devices}, Local Drug Delivery Products, Regenerative Products, Laser Systems, Therapeutic Agents), By Material Type (Implant Materials {Titanium Implants, Zirconia Implants}, Graft Materials {Autografts, Allografts, Xenografts, Synthetic Bone Grafts}), By End-user (Dental Clinics, Hospitals, Specialty Clinics, Academic and Research Institutes), Global Market Size, Segmental analysis, Regional Overview, Company share analysis, Leading Company Profiles And Market Forecast, 2025 – 2035

Industry Outlook

The Peri-Implantitis market accounted for USD 2.63 Billion in 2024 and is expected to reach USD 5.77 Billion by 2035, growing at a CAGR of around 7.4% between 2025 and 2035. The peri-implantitis market deals with products and services that can help in the prevention, diagnosis, and treatment of peri-implantitis, which is a chronic inflammatory disease that affects the soft and hard tissues surrounding an implant. If left untreated, this condition is mostly caused by bacterial infections and is responsible for the loss of adjuvant bone support surrounding implants.

The market consists of diagnostic technologies, antibacterial coatings, lasers for treatment and maintenance, and services. As the use of dental implants has grown in popularity around the world, more effective treatment options for peri-implantitis have emerged. This market is critical in improving the quality of delivery and the longevity of implantology.

Report Scope:

Market Dynamics

The increasing adoption of dental implants is due to growing awareness and aesthetic demands.

The growth rate of the peri-implantitis market is associated with some factors related to the rising incidence and awareness of dental implants. The increase in the number of dental implant procedures worldwide due to the advancement of restorative dentistry and consumer aspirations for cosmetic dentistry has a significant impact on the market growth. A growing geriatric population, likely to develop dental problems because of wear and tear over time, adds to the demand for implant products, consequently raising the rates of peri-implantitis. Recent advances in diagnosis and therapy, such as image-guided surgery or laser, as well as improved diagnostic aids for detecting the development of peri-implantitis, all contribute to market expansion.

Increased public awareness of oral health and healthcare organizations' initiatives and programs emphasize the importance of early diagnosis and intervention in the event of implant difficulties. In this regard, the advancement in dental tourism, especially in the growth markets, offers the availability of cheap treatment, thus increasing the target market. These factors put pressure on the need to develop an accurate diagnosis and adequate treatment strategies for peri-implantitis and stimulate the growth of the market.

The global rise in aging populations increases susceptibility to dental issues, fueling market growth.

The peri-implantitis market is driven by several crucial factors, the most notable of which is the increased use of dental implants. Thus, by combining the aspects of aging populations throughout the world with the rise in the prevalence of dental problems such as peri-implant diseases caused by recognized variables such as bone resorption and systemic health concerns, the market's growth is assured. Recent advances in dental technology, including improved implant materials and minute surgery, have increased implant success rates and popularity. They increase the chance of implant problems, such as peri-implantitis.

Furthermore, increased awareness of oral health and beauty concerns leads to the adoption of dental implants, which indirectly increases the requirement for peri-implantitis management. The increased use of imaging and biomarker-based diagnosis promotes early detection and treatment, driving market expansion. The expanding market for dental tourism in developing nations and a favorable insurance situation contribute to the expansion of the peri-implantitis solution market.

Limited awareness about peri-implantitis and its complications hampers market penetration.

The peri-implantitis market faces significant barriers, the most significant of which is the low level of understanding of the situation and its consequences. Patients and providers in many areas have limited awareness of the initial evidence, factors associated with, and consequences of peri-implantitis. A notable lack of knowledge exists as to the best ways to improve dental health education and access to sophisticated treatments in developing economic systems.

This is exacerbated by the fact that the ailment is chronic and does not cause symptoms in the early stages, and patients are unable to seek early treatment. Further, there is no single standard for treating peri-implantitis, resulting in a variety of clinical methods. Expensive treatment and current reimbursement policies also pose a major challenge to patients accessing specialized services. These factors limit the implementation and diffusion of effective solutions for the treatment of peri-implantitis and limit market development.

Untapped potential in developing regions with increasing dental care infrastructure

The global peri-implantitis market comprises adequate growth prospects, especially in developing nations with a developing dental implant network. These regions are experiencing a rise in investment in the healthcare sector, particularly in specialty dental clinics and training curricula that enhance healthcare equity delivery. An increase in disposable income and improved knowledge of oral health care in developing countries feed the denture market. Therefore, the need for peri-implantitis treatment grows, driving market growth.

The governments of the aforementioned regions and healthcare systems are also focusing on improving preventative healthcare and the early identification of oral problems. This may be interpreted as a positive condition for the market's future growth. Moreover, developments in less intrusive diagnostic equipment and therapeutic techniques can address the needs of low-income countries in these areas. These latent markets, combined with multiple industry partnerships and education programs by numerous players, imply a significant opportunity to meet unmet requirements in peri-implantitis prevention and treatment. This will fuel the market's long-term growth.

Use of AI and machine learning for early detection and personalized treatment plans

Several variables have been identified as influencing the peri-implantitis market. These include the importance of peri-implantitis treatment, which cannot be overstated as the number of cosmetic dental operations increases. With an increasing number of patients seeking permanent dentures, early and accurate detection of peri-implantitis, an inflammation surrounding the implants, has become critical.

AI and other advancements in technology, such as machine learning, are also improving early detection, thus increasing the chances of developing individual treatment plans special to the patient’s genetic makeup and lifestyle. Further, increasing concern for oral hygiene and implant maintenance, along with advancements in implant materials and techniques, are fueling the market growth. An increasing number of people with old age, who are more likely to suffer from oral care problems, also drives this market growth, as does an increased need for non-surgical procedures.

Industry Experts Opinion

"Patent™ has been demonstrated in two long-term studies to prevent peri-implantitis—and is the first and only implant system to have realized this clinical achievement!"

• Marco Waldner, CEO of Patent™ Dental Implant System

"The increasing prevalence of dental implant procedures worldwide is a significant factor driving the growth of the peri-implantitis market."

• Dr. Inga Boehncke, Periodontist

Segment Analysis

Based on the treatment type, the peri-implantitis market has been divided into Non-Surgical treatment, surgical treatment, and adjunctive therapies. Non-surgical therapy, particularly mechanical debridement, dominates the peri-implantitis market. Mechanical debridement entails etching the implant surface to remove mechanical components such as plaque and calculus, resulting in less inflammation and faster healing.

It is superior because it is less invasive, has less recovery time, and is less expensive than surgical procedures. Moreover, mechanical debridement can be conducted at dental clinics, making it more accessible to a larger number of patients. These findings are consistent with a shift toward more non-surgical procedures in the care of peri-implant diseases, which stems from a desire to take more preventative measures to ensure the long-term health of implants.

Based on the product type, the peri-implantitis market is segmented into implant-cleaning devices, local drug delivery systems, regenerative systems, lasers, and therapeutic products. The largest devices are those used to clean implants, such as ultrasonic scalers and air polishers. These devices are excellent for implant surface debridement as well as peri-implantitis prevention and control.

Ultrasonic scalers use high-frequency vibrations to eliminate bacterial stains, whereas air polishers use a stream of air and particulates to clean implants. These cleaning devices effectively maintain implant health and are consequently widely utilized in dental offices. They are also highly established in the market due to the ever-increasing demand for non-surgical cosmetic procedures that give excellent results without necessitating intrusive procedures that cause pain to the patient.

Regional Analysis

The North American peri-implantitis market is leading, owing to increased dental health awareness and the growing number of patients choosing dental implants. The United States has the greatest market share in the region due to its strong healthcare industry and widespread adoption of new dental equipment. Canada also contributes to market growth, as seen by an increasing number of dental practitioners and a shift toward prevention. Increased life expectancy, rising income, and the development of dynamic diagnostic and treatment processes are among the factors driving this industry.

Further, the demand for effective and minimally invasive therapies and regenerative medicine solutions is driving market expansion. However, challenges such as excessive treatment costs and insufficient insurance coverage may operate as business barriers to industry growth. Overall, the peri-implantitis market in North America is predicted to grow steadily in the future owing to the ongoing development of various therapeutic techniques and preventive measures.

The Asia-Pacific peri-implantitis market is predicted to rise steadily as more patients express interest in dental implants, dental tourism grows at a rapid pace, and nations such as Japan, China, and India have populations that age. Peri-implantitis, a prevalent sickness caused by dental implants, is driving the market need for technological advances developed by dental implant manufacturers. There are both established important players and new entrants offering laser therapy, antimicrobial treatments, and regenerative ones. Growth factors influencing markets include the rising incidence of periodontitis and the growing middle-income population with better access to health care. Furthermore, constant technology improvements in implantology and growth of the healthcare expenses across select jurisdictions should aid further market accretion in the future. However, factors that may threaten progression include high costs for differentiated treatment and inadequate availability of competent personnel in certain areas.

Competitive Landscape

The peri-implantitis market is very fragmented, and some of the prominent players include Pfizer Inc., Cadila Pharmaceuticals, R.N. Laboratories Pvt. Ltd., and Basic Pharma Life Science Pvt. Ltd. Currently, manufacturers such as Geistlich Pharma Inc., Straumann AG, Dentsply Sirona, and Zimmer Biomet are using their resources to work on enhanced biomaterial and implant technologies aimed at handling peri-implant diseases.

Straumann is working on an implant regeneration and anti-infection substance, and Dentsply Sirona is developing implant care solutions for peri-implantitis. Geistlich Pharma has also focused on regenerative treatments and advanced surgical solutions to prevent peri-implant infections. The growing trend towards less invasive surgical treatments and more active biomaterials is expected to boost competitiveness in this sector.

Peri-Implantitis Market, Company Shares Analysis, 2024

To explore in-depth analysis in this report - Request Free Sample Report

Recent Developments:

• In November 2024, FDA approved a locally applied antibiotic known as Arestin Implant in the management of peri-implantitis. This approval brings a lot of improvement to the type of non-surgical management of peri-implantitis, as it puts in the hands of the practitioners an effective means of managing this condition.
• In February 2024, Straumann has recently made the final acquisition of GalvoSurge which is a medical device company in Switzerland that specifically covers the dental implant care and maintenance market. Peri-implantitis support is another target area; GalvoSurge’s methods to help with treatment and its CE-marked device launched in 2020 will complement Straumann’s portfolio.

Report Coverage:

By Treatment Type

• Non-Surgical Treatments
  • Mechanical Debridement
  • Antiseptics
  • Antibiotic Therapy
  • Laser Therapy
• Surgical Treatments
  • Flap Surgery
  • Bone Grafting
  • Soft Tissue Augmentation
  • Implantoplasty
• Adjunctive Therapies

By Product

• Implant Cleaning Devices
  • Ultrasonic Scalers
  • Air-polishing Devices
• Local Drug Delivery Products
• Regenerative Products
• Laser Systems
• Therapeutic Agents

By Material Type

• Implant Materials
  • Titanium Implants
  • Zirconia Implants
• Graft Materials
  • Autografts
  • Allografts
  • Xenografts
  • Synthetic Bone Grafts

By End-Use

• Dental Clinics
• Hospitals
• Specialty Clinics
• Academic and Research

By Region

North America

• U.S.
• Canada

Europe

• U.K.
• France
• Germany
• Italy
• Spain
• Rest of Europe

Asia Pacific

• China
• Japan
• India
• Australia
• South Korea
• Singapore
• Rest of Asia Pacific

Latin America

• Brazil
• Argentina
• Mexico
• Rest of Latin America

Middle East & Africa

• GCC Countries
• South Africa
• Rest of Middle East & Africa

List of Companies:

• Pfizer Inc.
• Cadila Pharmaceuticals
• R.N. Laboratories Pvt. Ltd.
• Basic Pharma Life Science Pvt. Ltd.
• Prachi Pharmaceuticals Private Limited
• Geistlich Pharma Inc.
• Healthy Life Pharma Private Limited
• Straumann AG
• Dentsply Sirona
• Zimmer Biomet
• Nobel Biocare
• BioHorizons
• Osstem Implant
• Keystone Dental
• Neoss Limited

Frequently Asked Questions (FAQs)